Holen Sie sich die Stockscreener-App
359.58
0.16%
-0.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$360.16
Offen:
$359.5
24-Stunden-Volumen:
706.51K
Relative Volume:
2.15
Marktkapitalisierung:
$16.05B
Einnahmen:
$2.76B
Nettoeinkommen (Verlust:
$1.11B
KGV:
19.81
EPS:
18.15
Netto-Cashflow:
$898.10M
1W Leistung:
-0.62%
1M Leistung:
-1.30%
6M Leistung:
+16.38%
1J Leistung:
+59.45%
1-Tages-Spanne:
$357.99
$363.90
1-Wochen-Bereich:
$350.60
$383.00
52-Wochen-Spanne:
$208.62
$417.81
United Therapeutics Corp Stock (UTHR) Company Profile
Firmenname
United Therapeutics Corp
Sektor
Branche
Telefon
(301) 608-9292
Adresse
1000 SPRING ST, SILVER SPRING, MD
Vergleichen Sie UTHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
359.58 | 16.05B | 2.76B | 1.11B | 898.10M | 22.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Hochstufung | Goldman | Sell → Neutral |
| 2024-02-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Sell |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-20 | Bestätigt | BofA Securities | Underperform |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-02-11 | Eingeleitet | BTIG Research | Neutral |
| 2021-07-14 | Hochstufung | Argus | Hold → Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-02-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-06-25 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-03-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-27 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-01-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Eingeleitet | BofA/Merrill | Underperform |
| 2019-08-01 | Hochstufung | Jefferies | Underperform → Hold |
| 2019-08-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Hochstufung | Standpoint Research | Hold → Buy |
| 2018-08-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Barclays | Underweight |
| 2018-01-18 | Fortgesetzt | Credit Suisse | Underperform |
| 2017-12-27 | Bestätigt | Wedbush | Outperform |
| 2017-04-27 | Bestätigt | Wedbush | Outperform |
| 2017-03-30 | Eingeleitet | UBS | Sell |
| 2017-03-16 | Eingeleitet | Credit Suisse | Underperform |
Alle ansehen
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Insider Sell: Louis Sullivan Sells 26,209 Shares of United Thera - GuruFocus.com
United Therapeutics Co. (NASDAQ:UTHR) Director Sells $9,781,722.98 in Stock - MarketBeat
United Therapeutics director sells shares worth $9.78 million - Investing.com
United Therapeutics president and COO sells $3.7 million in stock - Investing.com India
United Therapeutics (NASDAQ:UTHR) Trading Down 4.4%Here's Why - MarketBeat
United Therapeutics 'no longer pursuing' nearly 350 acres in Hackett Hill area - The Union Leader
United Therapeutics president and COO sells $3.7 million in stock By Investing.com - Investing.com UK
United Therapeutics Makes History: First-Ever Genetically Modified Pig Kidney Transplant Success - StockTitan
United Therapeutics cancels plans to buy Hackett Hill property from Manchester - New Hampshire Business Review
Franklin Resources Inc. Grows Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Tidal Investments LLC Acquires 2,803 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Lord Abbett & CO. LLC Buys 46,170 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Oddo BHF Asset Management Sas Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Geode Capital Management LLC Purchases 45,566 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Tri Ri Asset Management Corp Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
iA Global Asset Management Inc. Lowers Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics president sells $3.45 million in stock By Investing.com - Investing.com Canada
United Therapeutics president sells $3.45 million in stock - Investing.com
Brophy Wealth Management LLC Invests $809,000 in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
With EPS Growth And More, United Therapeutics (NASDAQ:UTHR) Makes An Interesting Case - Simply Wall St
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Worldquant Millennium Advisors LLC - MarketBeat
State Street Corp Decreases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Dorsey Wright & Associates Purchases New Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) EVP Sells $2,882,649.00 in Stock - MarketBeat
United Therapeutics' EVP sells $2.88 million in stock - Investing.com India
United Therapeutics' EVP sells $2.88 million in stock By Investing.com - Investing.com Canada
United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Chevy Chase Trust Holdings LLC - MarketBeat
Janus Henderson Group PLC Acquires 50,409 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 1,531 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
PDT Partners LLC Reduces Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Edgestream Partners L.P. Buys New Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $76.21 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
PH-ILD Pipeline 2024: Clinical Trials Assessment, FDA - openPR
45,266 Shares in United Therapeutics Co. (NASDAQ:UTHR) Acquired by Erste Asset Management GmbH - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Has $10.44 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
BNP Paribas Financial Markets Has $12.25 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
True Wealth Design LLC Sells 3,274 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Cerity Partners LLC Acquires 4,005 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Fmr LLC Acquires 314,004 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Bank of Montreal Can - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Martingale Asset Management L P - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Holdings Trimmed by Crawford Fund Management LLC - MarketBeat
The 3.8% return this week takes United Therapeutics' (NASDAQ:UTHR) shareholders five-year gains to 314% - Yahoo Finance
United Therapeutics Co. (NASDAQ:UTHR) Shares Bought by Bridgewater Associates LP - MarketBeat
Glenmede Trust Co. NA Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics president sells shares worth $3.73 million By Investing.com - Investing.com Nigeria
Dai ichi Life Insurance Company Ltd Sells 1,412 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) COO Sells 10,000 Shares of Stock - MarketBeat
United Therapeutics president sells shares worth $3.73 million - Investing.com
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
United Therapeutics Corp-Aktie (UTHR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SULLIVAN LOUIS W | Director |
Dec 18 '24 |
Option Exercise |
175.43 |
15,000 |
2,631,450 |
31,260 |
| SULLIVAN LOUIS W | Director |
Dec 18 '24 |
Sale |
373.22 |
26,209 |
9,781,715 |
5,051 |
0.43%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):